TIVC
HealthcareTivic Health Systems, Inc. Common Stock
Live · XNAS · May 9, Close
What's Moving TIVC Today?
No stock-specific AI insight has been generated for TIVC yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Trading
TIVC News
20 articles- VALION BIO RECEIVES FIRST FDA-PRECEDENT STUDY PROTOCOL FROM NIAID FOR ENTOLIMOD™; FEDERAL AGENCY TO FULLY FUND BLA-ENABLING IN VIVO PROGRAM AND CO-NAVIGATE FDA SUBMISSIONYahoo Finance·May 5, 2026
- Valion Bio Appoints Melinda Lackey as General CounselYahoo Finance·May 4, 2026
- VALION BIO BRIEFS PENTAGON LEADERSHIP ON ENTOLIMOD™ FOR ACUTE RADIATION SYNDROMEYahoo Finance·Apr 28, 2026
- Tivic Health Systems Rebrands as Valion Bio, Reflecting Completed Transformation into a Late-Stage Biopharmaceutical Company with Government-Backed Asset and Potential Multiple Revenue Stream ModelYahoo Finance·Apr 23, 2026
- Tivic Health Selected to Present Entolimod™ as a Radiation Countermeasure and its Plans for an Oral Transmucosal Program to the Department of War Tech Watch Program on May 7thYahoo Finance·Apr 15, 2026
- Tivic Receives Formal Request for Information from Ukrainian Ministry of Health Regarding Strategic Stockpiling of EntolimodYahoo Finance·Mar 31, 2026
- Presenting on Emerging Growth Conference 91 Day 1 on April 1; Register to live streamYahoo Finance·Mar 31, 2026
- Tivic CEO To Present at the Upcoming Emerging Growth's April 2026 Virtual ConferenceYahoo Finance·Mar 27, 2026
- Tivic Secures NIAID Non-Clinical Evaluation Agreement for Entolimod, Targeting Gastrointestinal Acute Radiation SyndromeYahoo Finance·Mar 26, 2026
- Tivic Reports Full Year 2025 ResultsYahoo Finance·Mar 25, 2026
- Tivic Health CEO Letter to ShareholdersYahoo Finance·Mar 24, 2026
- Tivic To Report 2025 Year-End Financial Results Via Conference Call and Webcast on March 25th at 1:30pm PT / 4:30pm ETYahoo Finance·Mar 20, 2026
- Biotech Veteran Michael K. Handley Named CEO of Tivic Health Systems to Spearhead Strategic Expansion in BiopharmaYahoo Finance·Mar 4, 2026
- Tivic and BARDA Continue Discussions of Entolimod for Acute Radiation Syndrome on March 10Yahoo Finance·Feb 18, 2026
- Tivic, BARDA Discuss Entolimod(TM) for Acute Radiation Syndrome at TechWatch MeetingYahoo Finance·Jan 28, 2026
- Tivic to Showcase Strategic Pivot and Forward Outlook on Advancing Entolimod(TM) to Commercialization at DealFlow Discovery ConferenceYahoo Finance·Jan 26, 2026
- Presenting on Emerging Growth Conference 89 Day 2 on January 22; Register to live streamYahoo Finance·Jan 21, 2026
- Tivic CEO To Present at the Upcoming Emerging Growth's January 2026 Virtual ConferenceYahoo Finance·Jan 20, 2026
- Tivic Delivers 200x Scale-up in Manufacturing for Lead Drug Candidate Entolimod(TM) And Achieves Reproducible Yields, Potency and PurityYahoo Finance·Jan 12, 2026
- Tivic Announces Special Webcast To Discuss Its Recent Acquisition of CDMO Assets - Highlighting Near-Term Strategic Potential and Immediate Contributions to Accelerated Drug Development TimelinesYahoo Finance·Jan 8, 2026
All 20 articles loaded
Price Data
Fundamentals
Trading
About Tivic Health Systems, Inc. Common Stock
Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.